What is the ticker symbol for Nymox Pharmaceutical?

Nymox Pharmaceutical trades under the ticker NYMX on NASDAQ.

What sector does Nymox Pharmaceutical operate in?

Nymox Pharmaceutical is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NYMX in a portfolio?

PortView shows NYMX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Nymox Pharmaceutical (NYMX) Stock Analysis

NASDAQHealthcareBiotechnology

$0.20-0.05%

1-year price historyRange $0.19 – $1.02

52-week range$0.20

$0.17$0.74

What Nymox Pharmaceutical does

Nymox Pharmaceutical Corporation operates as a biopharmaceutical firm, primarily focused on the discovery and advancement of medications for the aging population across Canada, the United States, Europe, and other international regions. The company's leading experimental compound is Fexapotide Triflutate (NX-1207), which has successfully concluded Phase III clinical trials for benign prostatic hyperplasia treatment. It has also completed Phase II trials for localized low-grade prostate cancer and is currently in preclinical studies for hepatocellular carcinoma. In addition to its drug pipeline, Nymox develops and markets diagnostic products. These include NicAlert and TobacAlert, tests that utilize urine or saliva samples to identify the use of tobacco products. The company further offers AlzheimAlert, a proprietary urine-based assay designed to aid healthcare professionals in diagnosing Alzheimer's disease. Alongside this diagnostic tool, Nymox is actively researching and developing therapeutic treatments for Alzheimer's disease. Founded in 1989, the company is headquartered in Nassau, the Bahamas.

Key metrics

Market cap

$18.24M

P/E (TTM)

-2.86

EPS (TTM)

$-0.07

Beta

0.82

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$0.39

200-day avg

$0.39

52-week high

$0.74

52-week low

$0.17

CEO

Paul Averback DABP,

ETFs linked to NYMX

Broad-market and Healthcare sector ETFs an investor holding Nymox Pharmaceutical is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how NYMX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NYMX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Nymox Pharmaceutical?: Nymox Pharmaceutical trades under the ticker NYMX on NASDAQ.
Which exchange is NYMX listed on?: NYMX is listed on NASDAQ.
What sector does Nymox Pharmaceutical operate in?: Nymox Pharmaceutical is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NYMX in a portfolio?: PortView shows NYMX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.